Announcement PDF Appendix 2A - Application for quotation of securities Announcement Summary Entity name PARADIGM BIOPHARMACEUTICALS LIMITED.. Announcement Type New announcement Date of this announcement Wednesday January 29, 2025 The +securities to be quoted are: +Restricted securities where the escrow period has expired or is about to expire Total number of +securities to be quoted ASX +security code Security description PAR ORDINARY FULLY PAID Number of +securities to be quoted Issue date 125,000 25/01/2022 Refer to next page for full details of the announcement Appendix 2A - Application for quotation of securities 1/5 Appendix 2A - Application for quotation of securities Part 1 - Entity and announcement details 1.1 Name of entity PARADIGM BIOPHARMACEUTICALS LIMITED.. We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules. 1.2 Registered number type Registration number ACN 169346963 1.3 ASX issuer code PAR 1.4 The announcement is New announcement 1.5 Date of this announcement 29/1/2025 Appendix 2A - Application for quotation of securities 2/5 Appendix 2A - Application for quotation of securities Part 2 - Type of Issue 2.1 The +securities to be quoted are: +Restricted securities where the escrow period has expired or is about to expire 2.2 The +class of +securities to be quoted is: Additional +securities in a class that is already quoted on ASX ("existing class") Appendix 2A - Application for quotation of securities 3/5 Appendix 2A - Application for quotation of securities Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B Additional +securities to be quoted in an existing class as a result of escrow expiring on an existing class FROM (Existing Class) ASX +security code and description PARAT : ORDINARY FULLY PAID RESTRICTED TO (Existing Class) ASX +security code and description PAR : ORDINARY FULLY PAID Please state the number of +restricted securities where the escrow period has expired or is about to expire And the date the escrow restrictions have ceased or will cease 125,000 25/1/2025 Issue date 25/1/2022 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Issue details Number of +securities to be quoted 125,000 Are the +securities being issued for a cash consideration? Yes In what currency is the cash consideration being paid? What is the issue price per +security? AUD - Australian Dollar AUD 1.89000000 Any other information the entity wishes to provide about the +securities to be quoted Appendix 2A - Application for quotation of securities 4/5 Appendix 2A - Application for quotation of securities Part 4 - Issued capital following quotation Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise: The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application) ASX +security code and description Total number of +securities on issue PAR : ORDINARY FULLY PAID 389,428,603 4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue PARAAB : OPTION EXPIRING 09-FEB-2026 EX $0.65 2,500,000 PARAAC : PERFORMANCE RIGHTS 6,558,600 PARAT : ORDINARY FULLY PAID RESTRICTED Appendix 2A - Application for quotation of securities 0 5/5